We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Steps to outline how to improve breast cancer clinical care, outcomes and experience for patients has been sent in a letter to the NHS.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Projects granted during 2016 that have a primary purpose of translational and applied research - human cancer.
This revew evaluates the clinical trial evidence to determine how effective radiotherapy, surgery and corticosteroids are
Marburg virus is a Filovirus which, along with Ebola virus, can cause a severe and often fatal viral haemorrhagic fever (VHF).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Projects granted during 2016 that have a primary purpose of basic research, oncology.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Quarterly updates to the emergency presentations of cancer data by Public Health England.
Projects granted during 2015 that have a primary purpose of basic research: oncology.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).